Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia

Blood

Volumn 106, Issue 2, 2005, Pages 572-576

  Li, Zongdong ^a   Nardi, Michael A ^a   Karpatkin, Simon ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA3 INTEGRIN; GAG PROTEIN; GLYCOPROTEIN IIIA; LIPOXYGENASE; NEF PROTEIN; POL PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN;

ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EPITOPE MAPPING; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR CLONING; MOLECULAR MIMICRY; NUCLEOTIDE SEQUENCE; OXIDATION; PEPTIDE ANALYSIS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; THROMBOCYTOPENIA;

EID: 22144466585     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2005-01-0243     Document Type: Article

References (24)

1. Morris L, Distenfeld A, Amorosi E, Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982;96:714-717.
2. Najean Y, Rain JD. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med. 1994;123:415-420.
3. Walsh C, Nardi M, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually-active homosexual men. N Engl J Med. 1984;311:635-639.
4. Savona S, Nardi M, Karpatkin S. Thrombocytopenic purpura in narcotics addicts. Ann Intern Med. 1985;102:737-741.
5. Ratnoff O, Menitove J, Aster R, Lederman M. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of anti-hemophilic factor (factor VIII). N Engl J Med. 1983;308:439-442.
6. Karpatkin S. Autoimmune (idiopathic) thrombocytopenic purpura. Lancet. 1997;349:1531-1536.
7. Karpatkin S, Nardi M, Hymes K. Sequestration of anti-platelet GPIIIa antibody in rheumatoid factor-immune complexes of human immunodeficiency virus 1 thrombocytopenic patients. Proc Natl Acad Sci USA. 1995;92:2263-2267.
8. Nardi M, Karpatkin S. Antiidiotype antibody against platelet anti-GPIIIa contributes to the regulation of thrambocytopenia in HIV-1-ITP patients. J Exp Med. 2000;191:2093-2100.
9. Nardi M, Tomlinson S, Greco M, Karpatkin S. Complement-independent, peroxide induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell. 2001;106:551-561.
10. Nardi MA, Liu LX, Karpatkin S. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia. Proc Natl Acad Sci USA. 1997;94:7589-7594.
11. Nardi M, Feinmark S, Liang H, Li Z, Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest 2004;113:973-980.
12. Los Alamos National Library, http://www.hiv.lanl. gov/content/index. Accessed May 2004.
13. Damian R. Molecular mimickry: antigen sharing by parasite and host and its consequences. Am Nat 1964;98:129-149.
14. Rose N, Mackay I. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci. 2000;57:542-551.
15. Silvestris F, Williams RC Jr, Dammacco F. Autoreactivity in HIV-1 infection: the role of molecular mimicry. Clin Immunol Immunopathol. 1995;75:197-205.
16. Zandman-Goddard G, Shoenfeld Y. HIV and autoimmunity. Autoimmun Rev. 2002;1:329-337.
17. Schneider T, Harthus HP, Hildebrandt P, et al. Epitopes of the HIV-1-negative factor (nef) reactive with murine monoclonal antibodies and human HIV-1-positive sera. AIDS Res Hum Retroviruses. 1991;7:37-44.
18. Serres PF. Molecular mimicry between the trimeric ectodomain of the transmembrane protein of immunosuppressive lentiviruses (HIV-SIV-FIV) and interleukin 2. C R Acad Sci III 2000;323:1019-1029.
19. Trujillo JR, Rogers RA, Brain JD. Shared antigenic epitopes on the V3 loop of HIV-1 gp120 and proteins on activated human T cells. Virology. 1998;246:53-62.
20. Bettaieb A, Fromont P, Louache F, et al. Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood. 1992;80:162-169.
21. Chia WK, Blanchette V, Mody M, Wright JF, Freedman J. Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br J Haematol. 1998;103:1014-1022.
22. Wright JF, Blanchette VS, Wang H, et al. Characterization of platelet-reactive antibodies in children with varicella-associated acute immune thrombocytopenic purpura (ITP). Br J Haematol. 1996;95:145-152.
23. Bettaieb A, Oksenhendler E, Duedari N, Bierling P. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura. Clin Exp Immunol. 1996;103:19-23.
24. Kiepiela P, Leslie AJ, Honeyborne I, et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA. Nature. 2004;432:769-775.